" class="no-js "lang="en-US"> Appointments Archives - Page 33 of 45 - Medtech Alert
Monday, October 13, 2025

Sort by:

Date

Top Post

Almirall Appoints Mercedes Diz as VP, Corporate Strategy

Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]

Seegene Appoints Richard Creager as CEO of U.S. Subsidiary to Bolster U.S. Business

Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today announced the appointment of Richard S. Creager, Ph.D., […]

Targovax ASA Strengthens Management with Lubor Gaal as Chief Financial Officer

Targovax ASA (OSE: TRVX) a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid […]

OncoSec Announces Appointment of George Chi as Chief Financial Officer

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company focused on developing […]

Mnemo Therapeutics Names Robert LaCaze as Chief Executive Officer

Mnemo Therapeutics, a biotechnology company developing next-generation T cell therapies, today announced the appointment of Robert […]

PrecisionLife Announces Appointment of Colin Stubberfield as SVP Drug Discovery to Lead Development of its Precision Medicine Programs

PrecisionLife Limited, a global techbio company driving precision medicine in chronic diseases with drug discovery, […]

Biosion, Inc. Appoints Joel Edwards, MBA, as Chief Business Officer

Biosion, Inc. (“Biosion”), a global clinical stage biotechnology company, today announced the appointment of Joel Edwards as […]

Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors

Johnson & Johnson (NYSE: JNJ) announced today that Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, […]

Anil Jain, M.D., FACP, Joins Innovaccer Leadership Team as Chief Innovation Officer

Innovaccer Inc., the Health Cloud company, is pleased to welcome Anil Jain, M.D., FACP, to its […]

Enterprise Therapeutics Appoints Dr Niyati Prasad as Chief Medical Officer

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel […]

Dr. Blackford Middleton Joins ClosedLoop to Improve Clinical Decisions With AI

ClosedLoop, healthcare’s data science platform, today announced that renowned clinical informatics expert Dr. Blackford Middleton […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more